Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder

Bohdan Nosyk(Simon Fraser University), M. Eugenia Socías(University of British Columbia), Uwe Siebert(Harvard University), Brenda Carolina Guerra‐Alejos(Centre for Advancing Health Outcomes), Kyle M. Kampman(University of Pennsylvania), Jeong Eun Min(Centre for Advancing Health Outcomes), P. Todd Korthuis(Oregon Health & Science University), Mohammad Ehsanul Karim(Providence Health Care), Paul Gustafson, Shaun R. Seaman(Max Planck Society), Julie Bruneau(Inserm), Kevin Schnepel(Simon Fraser University), Robert W. Platt(McGill University), Lawrence C. McCandless(Simon Fraser University), Megan Kurz(Simon Fraser University), Fahmida Homayra(Centre for Advancing Health Outcomes), Ruyu Yan(Centre for Advancing Health Outcomes), Sander Greenland, Micah Piske(Center for Advancing Health), Thomas M. Loughin(Kansas State University), Paxton Bach(University of British Columbia)
JAMA
October 17, 2024
Cited by 60


Related Papers